Polyphyllin VI
Based on 6 publication(s) in Google Scholar
Polyphyllin VI, an active saponin, possess anti-cancer activities. Polyphyllin VI induces G2/M cell cycle arrest and triggers apoptosis. Polyphyllin VI induces caspase-1-mediated pyroptosis via the induction of ROS/NF-κB/NLRP3/GSDMD signal axis in non-small cell lung cancer.
For research use only. We do not sell to patients.
- Purity: 98.49%
- CAS No.: 55916-51-3
- Formula: C39H62O13
- Molecular Weight:738.90
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Polyphyllin VI
More- Cancer Res. 2025 Jun 6. [Abstract]
- ACS Nano. 2024 Nov 12;18(45):31401-31420. [Abstract]
- Dev Cell. 2025 Apr 18:S1534-5807(25)00206-0. [Abstract]
- Int Immunopharmacol. 2024 Nov 26:144:113684. [Abstract]
- Int Immunopharmacol. 2024 Oct 8;143(Pt 1):113334. [Abstract]
- Mediators Inflamm. 2022 Apr 21;2022:8007078. [Abstract]
-
Cell Proliferation/Viability Assay
-
Bio/Physico-chemical Assay
-
Cell Proliferation/Viability Assay
-
Cell Proliferation/Viability Assay
-
Flow Cytometry
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HL-60 | IC50 |
5.2 μg/mL
Compound: 5
|
Cytotoxicity against human HL60 cells by MTT assay
Cytotoxicity against human HL60 cells by MTT assay
|
[PMID: 11000027] |
Polyphyllin VI (0-16 μM; 48 h) significantly decreases the viability of A549, NCI-H1299 and HepaRG cells in a dose-dependent manner[1][2].
Polyphyllin VI (0.5-2 μM-1 μM; 24 h) significantly increases the percentage of A549, and NCI-H1299 cells in the G2/M stage in a dose-dependent manner[1].
Polyphyllin VI (0-12 μM-1 μM; 24 h) arrests HepaRG cells at S stage [2].
Polyphyllin VI (0-6 μM-1 μM; 24 h) activates the NLRP3 inflammasome[3].
Polyphyllin VI (0-6 μM-1 μM; 24 h) induces pyroptosis via ROS/NF-κB pathway om A549 and NCI-H1299 cells[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549, NCI-H1299, and HepaRG cells
-
Concentration:0 μM, 2.5 μM, 5.0 μM, 7.5 μM, 10 μM, 12.5 μM (A549, NCI-H1299), 0 μM, 2 μM, 4.0 μM, 6.0 μM, 8.0 μM, 10.0 μM, 12.0 μM, 16.0 μM (HepaRG)
-
Incubation Time:48 h (A549, NCI-H1299), 24 h and 48 h (HepaRG)
-
Result:Showed the IC50 value in NCI-H1299 cells after 48h treatment was 1.87±0.09 μM, 1.59±0.12 μM in A549[1].
Demonstrated the reduction of HepaRG cell viability ranged from 88.90% to 1.07% after 24 h, and from 79.06% to 0.71% after 48 h[2].
-
Cell Line:A549, NCI-H1299 cells
-
Concentration:0.5 μM, 1.0 μM, 2.0 μM
-
Incubation Time:24 h
-
Result:Showed those of A549 cells in G2/M phase were 25.14%±3.31%, 28.40%±4.63%, and 42.66%±1.30%, and NCI-H1299 cells were 27.99%±4.68%, 30.24%±3.61% and 38.51%±5.10% after treatment with 0.5, 1, and 2μM for 24 h, respectively.
-
Cell Line:HepaRG cells
-
Concentration:0 μM, 2.0 μM, 4.0 μM, 6.0 μM, 8.0 μM, 12.0 μM
-
Incubation Time:24 h
-
Result:Resulted the ratios of cells in the S and G0/G1 phase changed from 23.62%±0.14% to 34.01%±0.32%, 66.88%±1.15% to 54.00%±0.71%, respectively.
-
Cell Line:A549, NCI-H1299 cells
-
Concentration:0 μM, 3 μM, 4 μM, 5 μM, 6 μM
-
Incubation Time:24 h
-
Result:Resulted dose-dependently increasing the protein expression of NLRP3 and ASC, and the cleaved form of caspase-1, IL-1β, IL-18 and GSDMD in A549 and NCI-H1299 cells.
-
Cell Line:A549, NCI-H1299 cells
-
Concentration:0 μM, 3 μM, 4 μM, 5 μM, 6 μM
-
Incubation Time:24 h
-
Result:Resulted the expression of caspase-1 was significantly inhibited by N-acetyl-L-cysteine (NAC) in Polyphyllin VI -treated A549 and NCI-H1299 cells.
Polyphyllin VI (2.5-10 mg/kg; i.p.; 10 consecutive days) activates NLRP3 inflammasome in A549-bearing athymic nude mice[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A549 tumor xenografts subcutaneously inoculated into the right flank of the nude mice[1]
-
Dosage:2 mg/kg, 3 mg/kg, 4 mg/kg
-
Administration:Intraperitoneal Injection (i.p.)
-
Result:Resulted the reduction of tumor volume to 25.63%, 41.71%, and 40.41%, respectively, after 2 mg/kg, 3 mg/kg and 4 mg/kg treatment.
-
Animal Model:A549 tumor xenografts subcutaneously inoculated into the right flank of the nude mice[3]
-
Dosage:2.5 mg/kg, 5 mg/kg, 10 mg/kg
-
Administration:Intraperitoneal Injection (i.p.)
-
Result:Showed the expression of NLRP3, caspase-1, IL-1β and GSDMD was increasing in a dose manner.
Chemical Information
-
CAS No. 55916-51-3
-
Appearance Solid
-
Molecular Weight 738.90
-
Formula C39H62O13
-
Color White to off-white
-
SMILES
O[C@]1([C@@]2([H])O[C@]3(CC[C@@H](C)CO3)[C@H]1C)[C@]([C@@]4([H])C2)(CC[C@@]5([H])[C@@]4([H])CC=C6[C@@]5(CC[C@H](O[C@@](O[C@H](CO)[C@@H](O)[C@@H]7O)([H])[C@@H]7O[C@@](O[C@@H](C)[C@H](O)[C@H]8O)([H])[C@@H]8O)C6)C)C
-
Structure Classification
-
Initial Source
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
Cancer Res
Genome-Wide CRISPR Screening Reveals that mTOR Inhibition Initiates Ferritinophagy and Ferroptosis in Head and Neck Cancer. [Abstract]2025 Jun 6. PMID: 40479615
Polyphyllin VI purchased from MedChemExpress. Usage Cited in: Cancer Res. 2025 Jun 6. [Abstract]
Cell viability of Cal27 treated with INK128 (50 nM) for 72 hours was measured. From left to right, Z-VAD, Necrostatin-1 and Ac-FEID-CMK were used in combination with INK128. Positive controls were Etoposide (1.5 μM) and Polyphyllin VI (PPVI, 5 μM; 72 h). Cell viability was compared between monotherapy and combination therapy (mean ± SD, n = 6).
-
ACS Nano
Targeted Positron Emission Tomography-Tracked Biomimetic Codelivery Synergistically Amplifies Ferroptosis and Pyroptosis for Inducing Lung Cancer Regression and Anti-PD-L1 Immunotherapy Efficacy. [Abstract]2024 Nov 12;18(45):31401-31420. PMID: 39475541
Polyphyllin VI purchased from MedChemExpress. Usage Cited in: ACS Nano. 2024 Nov 12;18(45):31401-31420. [Abstract]
Polyphyllin VI (PPVI, 24 h) exhibited IC50 values of 6.41 μM and 16.26 μM in A549 and H1299 cells, respectively.
-
Dev Cell
2025 Apr 18:S1534-5807(25)00206-0. PMID: 40280135
Polyphyllin VI purchased from MedChemExpress. Usage Cited in: Dev Cell. 2025 Apr 18:S1534-5807(25)00206-0. [Abstract]
Measurement of caspase 1 (CASP1) activity in control A549 cells and A549 cells withCCN1 overexpression following treatment with RSL3 (0.5 μM, 24 h) or erastin (10 μM, 24h). Treatment with Polyphyllin VI (2 μM, 24 h) was set as the positive control to induce CASP1 activity.
-
Int Immunopharmacol
2024 Nov 26:144:113684. PMID: 39602960 -
Int Immunopharmacol
Stachyose ameliorates myocardial ischemia-reperfusion injury by inhibiting cardiomyocyte ferroptosis and macrophage pyroptosis. [Abstract]2024 Oct 8;143(Pt 1):113334. PMID: 39383784 -
Mediators Inflamm
Downregulated XBP-1 Rescues Cerebral Ischemia/Reperfusion Injury-Induced Pyroptosis via the NLRP3/Caspase-1/GSDMD Axis. [Abstract]2022 Apr 21;2022:8007078. PMID: 35497095
Polyphyllin VI purchased from MedChemExpress. Usage Cited in: Mediators Inflamm. 2022 Apr 21;2022:8007078. [Abstract]
The HT22 cells were, respectively, pretreated with Z-YVAD-FMK (20 μM) and Polyphyllin VI (4 μM) 30 min before exposing to OGD/R for 24 h. Cell viability was detected in HT22 cells using a CCK-8 assay.
Polyphyllin VI purchased from MedChemExpress. Usage Cited in: Mediators Inflamm. 2022 Apr 21;2022:8007078. [Abstract]
The HT22 cells were, respectively, pretreated with XBP-1 siRNA, 24 h before exposing to OGD/R for 24 h and Z-YVAD-FMK (20 μM) and Polyphyllin VI (4 μM) 30 min before exposing to OGD/R for 24 h. The quantity of necrotic cells and pyroptotic cells were analyzed by Annexin V and PI staining in each group.
Solvent & Solubility
DMSO : 100 mg/mL (135.34 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 1 mg/mL (1.35 mM); Clear solution
This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 1 mg/mL (1.35 mM); Clear solution
This protocol yields a clear solution of ≥ 1 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (10.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (286 KB)
-
SDS (252 KB)
- English - EN (252 KB)
- Français - FR (252 KB)
- Deutsch - DE (252 KB)
- Norwegian - NO (252 KB)
- Español - ES (252 KB)
- Swedish - SV (252 KB)
- Italian - IT (252 KB)
- Portuguese - PT (252 KB)
-
Handling Instructions (2659 KB)
References
[1]. Lin Z, et al. Anti-lung Cancer Effects of Polyphyllin VI and VII Potentially Correlate with Apoptosis In Vitro and In Vivo. Phytother Res. 2015 Oct;29(10):1568-76. [Content Brief]
[2]. Liu Y, et al. Molecular Mechanisms of Apoptosis in HepaRG Cell Line Induced by Polyphyllin VI via the Fas Death Pathway and Mitochondrial-Dependent Pathway. Toxins (Basel). 2018 May 15;10(5). pii: E201. [Content Brief]
[3]. Jin-Feng Teng, et al. Polyphyllin VI Induces Caspase-1-Mediated Pyroptosis via the Induction of ROS/NF-κB/NLRP3/GSDMD Signal Axis in Non-Small Cell Lung Cancer. Cancers (Basel). 2020 Jan 13;12(1):193. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.3534 mL | 6.7668 mL | 13.5336 mL | 33.8341 mL |
| 5 mM | 0.2707 mL | 1.3534 mL | 2.7067 mL | 6.7668 mL | |
| 10 mM | 0.1353 mL | 0.6767 mL | 1.3534 mL | 3.3834 mL | |
| 15 mM | 0.0902 mL | 0.4511 mL | 0.9022 mL | 2.2556 mL | |
| 20 mM | 0.0677 mL | 0.3383 mL | 0.6767 mL | 1.6917 mL | |
| 25 mM | 0.0541 mL | 0.2707 mL | 0.5413 mL | 1.3534 mL | |
| 30 mM | 0.0451 mL | 0.2256 mL | 0.4511 mL | 1.1278 mL | |
| 40 mM | 0.0338 mL | 0.1692 mL | 0.3383 mL | 0.8459 mL | |
| 50 mM | 0.0271 mL | 0.1353 mL | 0.2707 mL | 0.6767 mL | |
| 60 mM | 0.0226 mL | 0.1128 mL | 0.2256 mL | 0.5639 mL | |
| 80 mM | 0.0169 mL | 0.0846 mL | 0.1692 mL | 0.4229 mL | |
| 100 mM | 0.0135 mL | 0.0677 mL | 0.1353 mL | 0.3383 mL |